LabGenius' CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian - LabGenius

Combining human and machine intelligence to accelerate the discovery of advanced medicines.

LabGenius' CTO, Leonard Wossnig, discusses the intersection of synthetic biology, high-throughput assays, and machine learning in the quest for cancer drugs with Harry Glorikian

In the MediaLabGeniusJanuary 17, 2024